Cited by 237Psychotherapy Techniques and ApplicationsPsychoanalysis and Psychopathology ResearchTreatment of Major Depression

Pragmatic randomized controlled trial of long‐term psychoanalytic psychotherapy for treatment‐resistant depression: the Tavistock Adult Depression Study (TADS)

Open access
Fonagy, Peter, Rost, Felicitas, Carlyle, Jo‐anne, McPherson, Susan, Thomas, Rachel, Pasco Fearon, R.M., Goldberg, David, Taylor, David·2015·World Psychiatry

Abstract

This pragmatic randomized controlled trial tested the effectiveness of long‐term psychoanalytic psychotherapy (LTPP) as an adjunct to treatment‐as‐usual according to UK national guidelines (TAU), compared to TAU alone, in patients with long‐standing major depression who had failed at least two different treatments and were considered to have treatment‐resistant depression. Patients (N=129) were recruited from primary care and randomly allocated to the two treatment conditions. They were assessed at 6‐monthly intervals during the 18 months of treatment and at 24, 30 and 42 months during follow‐up. The primary outcome measure was the 17‐item version of the Hamilton Depression Rating Scale (HDRS‐17), with complete remission defined as a HDRS‐17 score ≤8, and partial remission defined as a HDRS‐17 score ≤12. Secondary outcome measures included self‐reported depression as assessed by the Beck Depression Inventory ‐ II, social functioning as evaluated by the Global Assessment of Functioning, subjective wellbeing as rated by the Clinical Outcomes in Routine Evaluation ‐ Outcome Measure, and satisfaction with general activities as assessed by the Quality of Life Enjoyment and Satisfaction Questionnaire. Complete remission was infrequent in both groups at the end of treatment (9.4% in the LTPP group vs. 6.5% in the control group) as well as at 42‐month follow‐up (14.9% vs. 4.4%). Partial remission was not significantly more likely in the LTPP than in the control group at the end of treatment (32.1% vs. 23.9%, p=0.37), but significant differences emerged during follow‐up (24 months: 38.8% vs. 19.2%, p=0.03; 30 months: 34.7% vs. 12.2%, p=0.008; 42 months: 30.0% vs. 4.4%, p=0.001). Both observer‐based and self‐reported depression scores showed steeper declines in the LTPP group, alongside greater improvements on measures of social adjustment. These data suggest that LTPP can be useful in improving the long‐term outcome of treatment‐resistant depression. End‐of‐treatment evaluations or short follow‐ups may miss the emergence of delayed therapeutic benefit.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/wps.20267

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is limited evidence of efficacy for long-term PDT for acute MDD treatment.

    “there is limited evidence of efficacy for acute MDD treatment.74”

    From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [74]

    The paper's introductory discussion (indexed under Abstract; page not supplied) says evidence-gathering on longer-term psychoanalytic treatments is in its early stages, supporting the claim that evidence is limited. But the trial studies treatment-resistant depression and does not establish that evidence is limited specifically for acute MDD treatment. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • There is only weak evidence, and only after prolonged treatment, for efficacy of long-term PDT for acute treatment of MDD.

    “However, there is only weak evidence, and only after prolonged treatment, for efficacy of long-term PDT for acute treatment of MDD.74,109”

    From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [74]

    The Abstract says evidence for longer-term psychoanalytic treatment was at an early stage and suggests benefits particularly over longer follow-up. The Outcomes section reports no significant difference in partial remission at the end of treatment, with differences emerging during follow-up. However, this trial studied treatment-resistant depression, not acute treatment of MDD generally, so it does not support that broader setting. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • PDT (up to 60 sessions over 18 months) did not significantly increase the likelihood of remission.

    “In contrast, PDT (up to 60 sessions over 18 months) did not significantly increase the likelihood of remission.74”

    From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [74]

    The Treatments section describes 60 sessions over 18 months, and the Outcomes section reports no significant increase in complete remission at the end of treatment or at 42 months. But the unqualified claim overlooks significant increases in partial remission during follow-up and in remission of the major-depression diagnosis at 18 months (Outcomes; Table 2). Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fonagy, P., Rost, F., Carlyle, J., McPherson, S., Thomas, R., Pasco Fearon, R. M., Goldberg, D., & Taylor, D.
Affiliations
  • University College London (GB)
  • The Tavistock and Portman NHS Foundation Trust (GB)
  • Adult Department, Tavistock & Portman NHS Foundation Trust London UK
  • University of Essex (GB)
  • Research Department of Clinical, Educational and Health Psychology University College London London UK
  • King's College London (GB)
Venue
World Psychiatry
Publisher
Wiley
Published
2015-09-25
Volume
14
Issue
3
Pages
312-321
ISSN
  • 1723-8617 (ISSN-L)
  • 2051-5545
OpenAlex
W2113367546
Cited by
237
References
49
Citations by year
2026: 7 · 2025: 12 · 2024: 18 · 2023: 17 · 2022: 12 · 2021: 52 · 2020: 21 · 2019: 26 · 2018: 29 · 2017: 22 · 2016: 16 · 2015: 5
FWCI
29.76
Type
journal article
Language
en
Open access
Locations
  • World Psychiatry (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Staff Publications Online (The Tavistock and Portman) (acceptedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Open Research Online (The Open University) (submittedVersion)
Funders
  • Wellcome Trust (095844/Z/11/Z, 095844)
  • National Institute for Health and Care Research (NF-SI-0510-10228, NF-SI-0514-10157)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
treatment-resistant depression, major depressive disorder, adjunctive psychotherapy, treatment remission, long-term follow-up, social functioning, quality of life, primary care depression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review